Errata: Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM)

156 weergaven

DOI:

10.3791/5755

Niet gepubliceerd

In dit artikel

Samenvatting

An erratum was issued for Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM).

Samenvatting

An erratum was issued for Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM). The disclosures were updated.

Protocol

An erratum was issued for Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM). The disclosures were updated from:

David Wong is co-founder of RNAmeTRIX Inc., a molecular diagnostic company. PeriRx LLC sublicensed intellectual properties pertaining to molecular diagnostics from RNAmeTRIX. David Wong is a consultant to PeriRx.

to

David T. Wong is co-founder of RNAmeTRIX Inc., a molecular diagnostic company. He holds equity in RNAmeTRIX, and serves as a company director and scientific advisor. The University of California also holds equity in RNAmeTRIX. Intellectual property that David T. Wong invented and which was patented by the University of California has been licensed to RNAmeTRIX. Additionally, he is a paid consultant to PeriRx.

Openbaarmakingen

No conflicts of interest declared.

Herprints en machtigingen

Toestemming aanvragen om de tekst of afbeeldingen van dit JoVE-artikel te hergebruiken

Toestemming aanvragen

Trefwoorden

Biomarkerdetectieexosoomanalysetoepassing van elektrische veldenbiomarkermetingexosoomvrijgavedetectiemethodebiomarkeranalyse